FastChain®: Catalent's Solution for Made-to-Order Gene Replacement Therapy Study

Abstract: A biopharma company developing a high-value gene therapy for a rare disorder faced several challenges in the study, including immediate treatment requirements, personalized dosing, and global reach. Discover how Catalent used FastChain® Demand-Led Supply to help the sponsor overcome these hurdles and ensure quick delivery and administration of this therapy to patients.